Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programsDURHAM, N.C., Jan. 22, 2025 (GLOBE ...
The Manhattan Mercury5d
Scorpius CEO acknowledges agreement with state to build Manhattan facility is 'no more'
Plans to build a long-promised biological manufacturing facility in Manhattan have fizzled, though company leaders prefer not ...
Business Insider8d
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
“This collaboration reinforces Scorpius’ reputation as a trusted and innovative biomanufacturing partner,” said Jeff Wolf, CEO of Scorpius. “ErythroMer™ is a groundbreaking advancement ...
Stockhouse7d
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer(TM)
“This collaboration reinforces Scorpius’ reputation as a trusted and innovative biomanufacturing partner,” said Jeff Wolf, CEO of Scorpius. “ErythroMer™ is a ...
Scorpius Holdings, Inc.: Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer
Scorpius Holdings, Inc (NYSE American: SCPX) ("Scorpius" or "the Company"), an integrated contract development and manufacturing organization ("CDMO") ...
Contract Pharma7d
Scorpius Partners with KaloCyte to Enhance Manufacturing Efficiencies for ErythroMer
Aims to accelerate the lead candidate’s journey toward clinical success and expand its reach to patients who need it.